Finding 382704 (2021-002)

Material Weakness
Requirement
AE
Questioned Costs
$1
Year
2021
Accepted
2024-03-21
Audit: 296290
Auditor: Forvis LLP

AI Summary

  • Core Issue: Funds were improperly claimed for patients who were either insured or received ineligible services.
  • Impacted Requirements: Compliance with eligibility criteria under 2 CFR Part 200 was not met, leading to questioned costs of $487.
  • Recommended Follow-Up: Establish stronger internal controls to verify patient insurance status and ensure timely refunds for ineligible claims.

Finding Text

Department of Health and Human Services HRSA COVID-19 Claims HRSA COVID-19 Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund Assistance Listing 93.461 Program Year 2021 Criteria: Activities Allowed or Unallowed and Eligibility – Per 2 CFR Part 200, services must be for individuals, who at the time the eligible services were provided, were uninsured as described in the terms and conditions. Condition: The Authority received program funds for a patient who had insurance coverage and two patients where the services performed were not eligible services as described in the terms and conditions. Questioned Costs: Known questioned costs are $487 calculated as the amount of federal funds received for individuals who had insurance at the time of service. Context: We tested 40 claims billed to the federal program during 2021, from a total population of 41,985 claims billed to the federal program. Errors were noted for three claims out of the 40 sampled. The sample was not intended to be, and was not, a statistically valid sample. One patient was initially considered uninsured, and the claim was billed to the federal program. It was later determined that the patient had insurance coverage and was not eligible for this program. In addition, two other patients were uninsured; however, the primary diagnosis was not COVID-19, as required by the terms and conditions. Accordingly, the services were not eligible for reimbursement. Effect or Potential Effect: Program funds were drawn to cover a claim for a patient who had insurance or whose services were not eligible for reimbursement. Cause: Internal controls were not adequately designed and implemented to ensure compliance with the program requirements. Identification as a Repeat Finding: Not a repeat finding. Recommendation: We recommend implementing controls to ensure review of patient insurance coverage and that the refund process is completed timely.

Corrective Action Plan

The Authority has performed a review of all patients who have had indications of additional health insurance on an account with a HRSA payment, and made appropriate refunds. A sample of HRSA paid claims were reviewed for ineligible diagnosis codes and appropriate refunds were made.

Categories

Questioned Costs Cash Management Eligibility Internal Control / Segregation of Duties

Other Findings in this Audit

  • 959146 2021-002
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $93.84M
93.461 Covid-19 Testing for the Uninsured $4.21M
21.019 Coronavirus Relief Fund $3.02M
93.697 Covid-19 Testing for Rural Health Clinics $500,000
93.788 Opioid Str $486,610
93.211 Telehealth Programs $373,149
93.914 Hiv Emergency Relief Project Grants $333,155
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $84,308
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $2,500